The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions
Open accessAbstract
Poly-adenosine diphosphate-ribose polymerases (PARPs) promote ADP-ribosylation, a highly conserved, fundamental posttranslational modification (PTM). PARP catalytic domains transfer the ADP-ribose moiety from NAD+ to amino acid residues of target proteins, leading to mono- or poly-ADP-ribosylation (MARylation or PARylation). This PTM regulates various key biological and pathological processes. In this review, we focus on the roles of the PARP family members in inflammation and host–pathogen interactions. Here we give an overview the current understanding of the mechanisms by which PARPs promote or suppress proinflammatory activation of macrophages, and various roles PARPs play in virus infections. We also demonstrate how innovative technologies, such as proteomics and systems biology, help to advance this research field and describe unanswered questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“Many investigations have focused on the major role of macrophages in such contexts and mechanisms for their proinflammatory activation (Murray and Wynn 2011; Wynn and Vannella 2016; Gisterå and Hansson 2017; Tabas and Lichtman 2017; Decano and Aikawa 2018; Funes et al. 2018; Swirski and Nahrendorf…”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148
Implications of macrophage polarization in autoimmunity
Funes, S. C., Rios, M., Escobar‐Vera, J., & Kalergis, A. M. (2018) · Immunology · doi:10.1111/imm.12910 · Cited by 1,005
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression
Jiao, S., Xia, W., Yamaguchi, H., Wei, Y., Chen, M.-K., Hsu, J.-M., Hsu, J. L., Yu, W.-H., Du, Y., Lee, H.-H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3215 · Cited by 981
Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., & Li, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.004 · Cited by 778 · cited 1×
“Various signal-transduction pathways participate in macrophage activation, which are often regulated by PTMs such as phosphorylation and acetylation (Tietzel and Mosser 2002; Park et al. 2011; Zhou et al. 2014; Nakano et al. 2016; Vergadi et al. 2017; Dean et al. 2019).”
BackgroundPARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · cited 10×
“In LPS-stimulated macrophages, an increase in reactive oxygen species induces DNA damage, which in turn activates PARP1, leading to a reduction of available NAD±.”
BackgroundInfluentialDunphy, G., Flannery, S. M., Almine, J. F., Connolly, D. J., Paulus, C., Jønsson, K. L., Jakobsen, M. R., Nevels, M. M., Bowie, A. G., & Unterholzner, L. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.034 · Cited by 648 · cited 1×
“Recent work showed that PARP inhibition in combination with PD-1/PD-L1 blockade could be effective for BRCA1-deficient tumors by activating antigen presenting cells such as dendritic cells via the cGAS-STING pathway (Jiao et al. 2017; Ding et al. 2018; Dunphy et al. 2018).”
BackgroundMonocyte-macrophages and T cells in atherosclerosis
Tabas, I., & Lichtman, A. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.008 · Cited by 646
PARP inhibition elicits STING-dependent antitumor immunity in brca1-deficient ovarian cancer
Ding, L., Kim, H.-J., Wang, Q., Kearns, M., Jiang, T., Ohlson, C. E., Li, B. B., Xie, S., Liu, J. F., Stover, E. H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.054 · Cited by 572 · cited 1×
“Recent work showed that PARP inhibition in combination with PD-1/PD-L1 blockade could be effective for BRCA1-deficient tumors by activating antigen presenting cells such as dendritic cells via the cGAS-STING pathway (Jiao et al. 2017; Ding et al. 2018; Dunphy et al. 2018).”
BackgroundAbandoning M1/M2 for a Network Model of Macrophage Function
Nahrendorf, M., & Swirski, F. K. (2016) · Circulation Research · doi:10.1161/circresaha.116.309194 · Cited by 525 · cited 1×
“Recent understanding, however, suggests that macrophage heterogeneity is more complex and multidimensional than the M1/M2 dichotomy (Murray et al. 2014; Nahrendorf and Swirski 2016; Decano and Aikawa 2018).”
BackgroundCG dinucleotide suppression enables antiviral defence targeting non-self RNA
Takata, M. A., Gonçalves-Carneiro, D., Zang, T. M., Soll, S. J., York, A., Blanco-Melo, D., & Bieniasz, P. D. (2017) · Nature · doi:10.1038/nature24039 · Cited by 398
A Role of Poly (ADP-Ribose) Polymerase in NF- B Transcriptional Activation
Hassa, P. O., & Hottiger, M. O. (1999) · Biological Chemistry · doi:10.1515/bc.1999.118 · Cited by 296 · cited 1×
“…involve the interplay between PARP1 and nuclear factor κB (NF-κB), a key 342 GENES & DEVELOPMENT transcription factor in immunity and various other biological processes (Hassa and Hottiger 1999; Hassa et al. 2005; Liu et al. 2012a; Minotti et al. 2015; Bohio et al. 2019; Kunze and Hottiger 2019).”
BackgroundCameron, A. M., Castoldi, A., Sanin, D. E., Flachsmann, L. J., Field, C. S., Puleston, D. J., Kyle, R. L., Patterson, A. E., Hässler, F., Buescher, J. M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0336-y · Cited by 269
Research works printed but not linked: 164
- 10.1073/pnas.1812130115 · DOI
- 10.3389/fcvm.2019.00016 · DOI · Paper page
- 10.1182/blood.V96.13.4328 · DOI
- 10.1074/jbc.M505408200 · DOI · Paper page
- 10.4049/jimmunol.179.1.305 · DOI
- 10.1016/S0022-2836(03)00473-X · DOI
- 10.1128/JVI.79.5.2973-2978.2005 · DOI
- 10.1128/JVI.00733-12 · DOI
- 10.1128/JVI.03443-13 · DOI · Paper page
- 10.1128/JVI.74.23.11278-11285.2000 · DOI
- 10.1016/j.febslet.2012.09.026 · DOI
- 10.1038/onc.2012.448 · DOI
- 10.3389/fimmu.2019.01563 · DOI
- 10.1111/bph.13748 · DOI · Paper page
- 10.1016/0167-4889(91)90228-P · DOI
- 10.1128/JVI.77.21.11555-11562.2003 · DOI · Paper page
- 10.4049/jimmunol.1801616 · DOI
- 10.1128/mBio.00151-11 · DOI · Paper page
- 10.1128/JVI.01668-12 · DOI
- 10.4049/jimmunol.1701117 · DOI
- 10.1038/s41598-017-14156-8 · DOI
- 10.1073/pnas.1302564110 · DOI
- 10.1371/journal.ppat.1007166 · DOI
- 10.1182/blood-2008-03-144121 · DOI
- 10.1073/pnas.1017082108 · DOI
- 10.4049/jimmunol.1301106 · DOI
- 10.1128/JVI.00559-15 · DOI
- 10.1371/journal.pgen.1004403 · DOI · Paper page
- 10.1016/j.cbpa.2018.11.001 · DOI
- 10.3389/fcvm.2018.00097 · DOI
- 10.1128/JVI.79.8.4640-4650.2005 · DOI
- 10.1016/0168-1702(86)90078-X · DOI
- 10.3389/fcvm.2018.00003 · DOI
- 10.1007/s11010-019-03510-1 · doi:10.1007/s11010-019-03510-1
- 10.1016/j.autrev.2019.102369 · DOI
- 10.1371/journal.pone.0037352 · DOI
- 10.1074/jbc.M701465200 · DOI · Paper page
- 10.1038/srep41746 · DOI
- 10.1128/JVI.00713-06 · DOI · Paper page
- 10.1128/JVI.02082-08 · DOI
- 10.1128/JVI.02596-14 · DOI
- 10.1128/mBio.01721-16 · DOI · Paper page
- 10.1016/j.tim.2017.11.011 · DOI
- 10.1128/JVI.70.6.3992-4000.1996 · DOI
- 10.1038/s41418-019-0326-5 · DOI
- 10.1126/science.1074276 · DOI · Paper page
- 10.1073/pnas.0506981103 · DOI
- 10.1074/jbc.M611283200 · DOI
- 10.3389/fcvm.2018.00134 · DOI
- 10.1016/0014-5793(91)81034-6 · DOI · Paper page
- 10.1128/JVI.00495-12 · DOI
- 10.1016/j.virol.2017.11.020 · DOI
- 10.1371/journal.ppat.1007756 · DOI · Paper page
- 10.1128/JVI.01743-19 · DOI
- 10.5230/jgc.2019.19.e29 · DOI
- 10.1073/pnas.0607063104 · DOI · Paper page
- 10.1038/s41564-019-0428-3 · DOI
- 10.1128/MCB.23.22.8282-8294.2003 · DOI
- 10.1073/pnas.051633498 · DOI
- 10.1371/journal.pone.0007430 · DOI
- 10.1016/j.carpath.2010.03.007 · DOI
- 10.1007/BF03402154 · DOI
- 10.1074/jbc.M507553200 · DOI · Paper page
- 10.1038/ni.1963 · DOI · Paper page
- 10.1021/acs.jproteome.8b00895 · DOI
- 10.1111/j.1742-4658.2006.05442.x · DOI
- 10.1016/j.it.2019.08.003 · DOI
- 10.1146/annurev-biochem-060614-034506 · DOI · Paper page
- 10.1016/j.tibs.2009.12.003 · DOI · Paper page
- 10.1038/ncomms8882 · DOI · Paper page
- 10.1182/blood-2014-07-588046 · DOI
- 10.1038/ncomms12849 · DOI · Paper page
- 10.1038/nsmb.2523 · DOI · Paper page
- 10.1067/mva.1987.avs0060147 · doi:10.1067/mva.1987.avs0060147
- 10.1128/MCB.02351-05 · DOI
- 10.1038/ncb2593 · DOI · Paper page
- 10.1006/bbrc.1999.1146 · DOI
- 10.1128/JVI.78.16.8931-8934.2004 · DOI
- 10.1016/j.bbrc.2005.06.104 · DOI
- 10.1371/journal.pgen.0040021 · DOI · Paper page
- 10.1016/j.molcel.2008.08.009 · DOI · Paper page
- 10.1073/pnas.89.17.8259 · DOI · Paper page
- 10.1093/intimm/dxv010 · DOI
- 10.1073/pnas.1621508114 · DOI
- 10.4110/in.2016.16.4.201 · DOI
- 10.1016/j.it.2018.12.006 · DOI
- 10.1007/978-1-4939-6993-7_11 · DOI
- 10.1371/journal.ppat.1007798 · DOI
- 10.1073/pnas.1310604110 · DOI
- 10.1083/jcb.201402114 · DOI · Paper page
- 10.1016/j.molcel.2011.04.015 · DOI · Paper page
- 10.1371/journal.ppat.1006864 · DOI
- 10.1128/JVI.05897-11 · DOI
- 10.1016/j.antiviral.2015.09.001 · doi:10.1016/j.antiviral.2015.09.001
- 10.1128/JVI.00705-16 · DOI · Paper page
- 10.1371/journal.ppat.1006145 · DOI · Paper page
- 10.1126/scisignal.aas9332 · DOI
- 10.1128/JVI.00715-19 · DOI
- 10.1016/j.humimm.2012.02.002 · DOI
- 10.1073/pnas.1114981109 · DOI · Paper page
- 10.1073/pnas.1509745112 · DOI
- 10.1016/j.vetmic.2014.11.023 · DOI
- 10.1371/journal.ppat.1003494 · DOI · Paper page
- 10.1038/ncomms12917 · DOI · Paper page
- 10.1038/nri.2017.63 · DOI · Paper page
- 10.1073/pnas.1621485114 · DOI · Paper page
- 10.1074/jbc.M110.157768 · DOI
- 10.1016/j.jaci.2012.06.015 · DOI
- 10.1111/imm.12515 · DOI
- 10.1038/s41590-018-0255-3 · DOI · Paper page
- 10.1128/MCB.00196-15 · DOI
- 1971, Splitting of the ribose–ribose linkage of poly(adenosine diphosphate-robose) by a calf thymus extract, J Biol Chem, 246, 6362, 10.1016/S0021-9258(18)61798-3 · doi:10.1016/s0021-9258(18)61798-3
- 10.1016/j.jhep.2016.10.023 · DOI · Paper page
- 10.1128/JVI.01601-06 · DOI · Paper page
- 10.1016/j.immuni.2014.06.008 · DOI · Paper page
- 10.1161/ATVBAHA.116.306926 · DOI
- 10.4049/jimmunol.0901568 · DOI
- 10.1038/srep41962 · DOI
- 10.1128/JVI.05785-11 · DOI
- 10.1002/jmv.23443 · doi:10.1002/jmv.23443
- 10.1074/jbc.M510290200 · DOI · Paper page
- 10.1093/emboj/18.16.4446 · DOI · Paper page
- 10.3389/fcvm.2019.00101 · DOI
- 10.3389/fimmu.2019.02103 · DOI
- 10.1161/CIRCULATIONAHA.106.668756 · DOI
- 10.1074/jbc.M408435200 · DOI
- 10.1016/j.virol.2009.03.031 · DOI
- 10.1016/j.abb.2011.02.019 · DOI
- 10.3389/fphar.2019.00172 · DOI
- 10.1146/annurev-biochem-060815-014935 · DOI · Paper page
- 10.1016/j.jprot.2015.07.024 · DOI
- 10.1371/journal.pone.0083127 · DOI
- 10.1111/imm.12099 · DOI · Paper page
- 10.1038/nsmb.2521 · DOI · Paper page
- 10.1021/cr5004248 · DOI
- 10.1186/1471-2164-9-171 · DOI
- 10.1038/s41590-019-0527-6 · DOI
- 10.1074/jbc.M116.726729 · DOI
- 10.1186/s12985-015-0433-y · DOI
- 10.1038/s41577-018-0065-8 · DOI · Paper page
- 10.1128/JVI.01909-16 · DOI
- 10.1128/JVI.02333-09 · DOI
- 10.2741/tietzel · DOI
- 10.1113/EP087499 · DOI
- 10.1038/ncb1201-1035 · DOI · Paper page
- 10.1038/ncomms2672 · DOI · Paper page
- 10.1093/cvr/cvm110 · DOI
- 10.1038/ncomms3240 · DOI · Paper page
- 10.1038/nbt.2121 · DOI · Paper page
- 10.1371/journal.pone.0039159 · DOI
- 10.1371/journal.pone.0079757 · DOI
- 10.1128/JVI.01487-16 · DOI
- 10.1074/jbc.M114.589515 · DOI
- 10.1099/jgv.0.000982 · DOI
- 10.1128/JVI.01514-12 · DOI
- 10.1128/JVI.03015-12 · DOI
- 10.1038/ni.3422 · DOI · Paper page
- 10.4049/jimmunol.1400359 · DOI
- 10.1016/j.molcel.2017.04.028 · DOI · Paper page
- 10.1182/blood-2013-05-503250 · DOI
- 10.1038/ni.3279 · DOI · Paper page
- 10.1128/JVI.00001-19 · DOI
- 10.1128/JVI.00088-17 · DOI
- 10.1073/pnas.1101676108 · DOI · Paper page
Cited by
Heer, C. D., Sanderson, D. J., Voth, L. S., Alhammad, Y. M. O., Schmidt, M. S., Trammell, S. A. J., Perlman, S., Cohen, M. S., Fehr, A. R., & Brenner, C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015138 · Cited by 192
Self-citationAlegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
A viral ADP-ribosyltransferase attaches RNA chains to host proteins
Wolfram-Schauerte, M., Pozhydaieva, N., Grawenhoff, J., Welp, L. M., Silbern, I., Wulf, A., Billau, F. A., Glatter, T., Urlaub, H., Jäschke, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06429-2 · Cited by 53
Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
Maggiore, A., Casale, A. M., Toscanelli, W., Cappucci, U., Rotili, D., Grieco, M., Gagné, J.-P., Poirier, G. G., d’Erme, M., & Piacentini, L. (2022) · Cells · doi:10.3390/cells11081284 · Cited by 40
Metadata
- Authors
- Fehr, A. R., Singh, S. A., Kerr, C. M., Mukai, S., Higashi, H., & Aikawa, M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2020-02-06
- Volume
- 34
- Issue
- 5-6
- Pages
- 341-359
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W3005531462
- Cited by
- 214
- References
- 15
- Type
- posted content
- Language
- en
- Open access
- diamond
- Funders
- National Institutes of Health (CoBRE P20 GM113117-02, K22 AI134993-01, R01 HL126901)
- Kowa Company, Ltd.
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.